Should I buy or sell Flora Growth stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Flora Growth in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" FLGC shares. View FLGC analyst ratings or view top-rated stocks .

What is Flora Growth's stock price target for 2024?

2 brokerages have issued 1-year price targets for Flora Growth's stock. Their FLGC share price targets range from $20.00 to $60.00. On average, they anticipate the company's share price to reach $40.00 in the next year. This suggests a possible upside of 3,393.4% from the stock's current price. View analysts price targets for FLGC or view top-rated stocks among Wall Street analysts .

How have FLGC shares performed in 2023?

Flora Growth's stock was trading at $4.5520 at the start of the year. Since then, FLGC shares have decreased by 74.8% and is now trading at $1.1450. View the best growth stocks for 2023 here .

Are investors shorting Flora Growth?

Flora Growth saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 117,500 shares, an increase of 9.1% from the October 31st total of 107,700 shares. Based on an average daily volume of 178,400 shares, the days-to-cover ratio is presently 0.7 days. Currently, 2.0% of the shares of the company are short sold. View Flora Growth's Short Interest .

When is Flora Growth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our FLGC earnings forecast .

How were Flora Growth's earnings last quarter?

Flora Growth Corp. (NASDAQ:FLGC) issued its quarterly earnings results on Wednesday, November, 8th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.15. The firm had revenue of $17.32 million for the quarter, compared to analyst estimates of $21.13 million. Flora Growth had a negative net margin of 84.86% and a negative trailing twelve-month return on equity of 56.02%.

What ETF holds Flora Growth's stock ?

Global X Cannabis ETF holds 443,087 shares of FLGC stock, representing 3.38% of its portfolio.

When did Flora Growth's stock split?

Shares of Flora Growth reverse split on the morning of Friday, June 9th 2023. The 1-20 reverse split was announced on Friday, June 9th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 9th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Flora Growth IPO?

(FLGC) raised $15 million in an initial public offering (IPO) on Tuesday, May 11th 2021. The company issued 3,300,000 shares at $4.00-$5.00 per share. Boustead Securities served as the underwriter for the IPO.

Who are Flora Growth's major shareholders?

Flora Growth's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (7.24%) and Armistice Capital LLC (5.45%).

How do I buy shares of Flora Growth?

Shares of FLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Flora Growth Stock Price, News & Analysis (NASDAQ:FLGC)

$1.14

-0.24 (-17.33%)

(As of 12/5/2023 ET)

Compare

Today's Range: $1.02
▼
$1.39
50-Day Range: $0.67
▼
$1.39
52-Week Range: $0.63
▼
$11.90

Volume: 227,539 shs
Average Volume: 103,444 shs
Market Capitalization: $9.40 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $40.00

Flora Growth MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 3,393.4% Upside
$40.00 Price Target
Short Interest: Healthy
1.95% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.99 out of 5 stars

Medical Sector

498th out of 949 stocks

Pharmaceutical Preparations Industry

216th out of 421 stocks

3.5

Analyst's Opinion

Consensus Rating
Flora Growth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $40.00, Flora Growth has a forecasted upside of 3,393.4% from its current price of $1.15.
Amount of Analyst Coverage
Flora Growth has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.95% of the float of Flora Growth has been sold short.
Short Interest Ratio / Days to Cover
Flora Growth has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Flora Growth has recently increased by 9.10%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Flora Growth does not currently pay a dividend.
Dividend Growth
Flora Growth does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FLGC.

2.3

News and Social Media Coverage

News Sentiment
Flora Growth has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Flora Growth this week, compared to 1 article on an average week.
Search Interest
1 people have searched for FLGC on MarketBeat in the last 30 days.
MarketBeat Follows
5 people have added Flora Growth to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Flora Growth insiders have not sold or bought any company stock.
Percentage Held by Insiders
17.60% of the stock of Flora Growth is held by insiders. A high percentage of insider ownership can be a sign of company health.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Flora Growth is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Flora Growth is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Flora Growth has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Flora Growth Stock (NASDAQ:FLGC)

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers fruit juices and canned goods in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it provides beverage products; cannabis formulations to treat ailments, such as anxiety, insomnia, and pain. The company sells its products under the JustCBD, Vessel, and Mambe, as well as Stardog Loungewear, No Cap Hemp Co, Original Hemp, Kalaya, and Mind Naturals brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.

FLGC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FLGC Stock News Headlines

December 3, 2023 | americanbankingnews.com

Flora Growth Corp. (NASDAQ:FLGC) Sees Significant Increase in Short Interest

November 16, 2023 | investorplace.com

Why Is Flora Growth (FLGC) Stock Up 7% Today?

December 6, 2023 | Edge On The Street (Ad)

Henry Ford Would NEVER Have Seen This Coming

In 1908, Henry Ford used a metal called vanadium in his Model T cars. Over a century later, automakers still turn to vanadium to make car bodies lighter and stronger. Today, this under-appreciated metal plays the starring role in cutting-edge battery tech set to revolutionize the energy storage market.

November 10, 2023 | msn.com

Blooming: Flora Growth's First Profitable Quarter Amid Strategic Shifts

November 8, 2023 | finance.yahoo.com

Flora Growth Corp. Reports Record Q3 2023 with Net Income of $1.1 Million and EBITDA of $0.9 Million

October 26, 2023 | finance.yahoo.com

LIFEIST WELLNESS INC. (M5B.BE)

October 25, 2023 | bizjournals.com

Flora Growth says it will challenge attempt to terminate M&A deal

October 25, 2023 | finanznachrichten.de

Lifeist Wellness Inc.: Lifeist Terminates Agreement for Sale of Australian Vapes

December 6, 2023 | Edge On The Street (Ad)

Henry Ford Would NEVER Have Seen This Coming

October 25, 2023 | finance.yahoo.com

Lifeist Terminates Agreement for Sale of Australian Vapes

October 16, 2023 | finance.yahoo.com

Flora Growth Corp. Announces Resignation of Director

October 4, 2023 | bizjournals.com

Former Flora Growth CEO steps down as director

October 2, 2023 | finance.yahoo.com

Flora Growth Corp. Announces Transition of Hussein Rakine from Director to Special Advisor

September 21, 2023 | benzinga.com

Why Flora Growth (FLGC) Shares Hit A New 52-Week Low Today

September 19, 2023 | finance.yahoo.com

Flora Growth Corp. Announces Pricing of $2.7 Million Registered Direct Offering and Concurrent Private Placement

September 18, 2023 | msn.com

Lifeist to sell non-core subsidiary Australian Vapes for $1.9 million

September 18, 2023 | benzinga.com

Global Weed Brand To Buy Australian Vaporizes For $1.7M In Shares

September 18, 2023 | finance.yahoo.com

Lifeist Announces Sale of Non-core Subsidiary Australian Vapes

August 28, 2023 | finance.yahoo.com

Cannabis company merges with German firm to grow market share in Europe

August 18, 2023 | benzinga.com

Global Cannabis Producer Expands Footprint In Germany Via Partnership With Local MMJ Company

August 17, 2023 | finance.yahoo.com

Flora Growth Corp. and TruHC Pharma GmbH Establish Strategic Partnership to Grow Market Share in Germany

August 10, 2023 | finance.yahoo.com

Flora Growth Corp. Reports Second Quarter 2023 Financial Results

August 2, 2023 | benzinga.com

Hulk Hogan Launching Hemp-Derived Pre-Rolls, CBD And Delta-8 Products In Partnership With Flora Growth

August 1, 2023 | msn.com

Flora Growth signs global partnership to sell Hulk Hogan cannabis products

August 1, 2023 | finance.yahoo.com

Flora Growth Corp. Announces an Exclusive Worldwide Partnership with Legendary Superstar Hulk Hogan

July 30, 2023 | thestreet.com

Flora Growth Corp.

July 26, 2023 | benzinga.com

Flora Growth Colombian Assets Sale To Contribute To Anticipated Annual Savings Of $6.1M

See More Headlines

Receive FLGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Flora Growth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/08/2023
Today: 12/06/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/29/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:FLGC
CUSIP: N/A
CIK: 1790169
Web: floragrowth.ca
Phone: 954-842-4989
Fax: N/A
Employees: 337
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $40.00
High Stock Price Target: $60.00
Low Stock Price Target: $20.00
Potential Upside/Downside: +3,393.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($10.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-52,420,000.00
Net Margins: -84.86%
Pretax Margin: N/A
Return on Equity: -56.02%
Return on Assets: -33.95%

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 1.44
Quick Ratio: 0.80

Sales & Book Value

Annual Sales: $72.42 million
Price / Sales: 0.13
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $14.66 per share
Price / Book: 0.08

Miscellaneous

Outstanding Shares: 8,209,000
Free Float: 6,764,000
Market Cap: $9.40 million
Optionable: Not Optionable
Beta: 1.58

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Clifford A. Starke (Age 39)
CEO & Director
Mr. Dany Vaiman (Age 37)
Chief Financial Officer
Mr. Aaron Atin (Age 38)
Corporate Secretary
Ms. Holly Bell
Vice President of Regulatory Affairs

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

FLGC Stock Analysis - Frequently Asked Questions

Should I buy or sell Flora Growth stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Flora Growth in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" FLGC shares.
View FLGC analyst ratings or view top-rated stocks.
What is Flora Growth's stock price target for 2024?: 2 brokerages have issued 1-year price targets for Flora Growth's stock. Their FLGC share price targets range from $20.00 to $60.00. On average, they anticipate the company's share price to reach $40.00 in the next year. This suggests a possible upside of 3,393.4% from the stock's current price.
View analysts price targets for FLGC or view top-rated stocks among Wall Street analysts.
How have FLGC shares performed in 2023?: Flora Growth's stock was trading at $4.5520 at the start of the year. Since then, FLGC shares have decreased by 74.8% and is now trading at $1.1450.
View the best growth stocks for 2023 here.
Are investors shorting Flora Growth?: Flora Growth saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 117,500 shares, an increase of 9.1% from the October 31st total of 107,700 shares. Based on an average daily volume of 178,400 shares, the days-to-cover ratio is presently 0.7 days. Currently, 2.0% of the shares of the company are short sold.
View Flora Growth's Short Interest.
When is Flora Growth's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our FLGC earnings forecast.
How were Flora Growth's earnings last quarter?: Flora Growth Corp. (NASDAQ:FLGC) issued its quarterly earnings results on Wednesday, November, 8th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.15. The firm had revenue of $17.32 million for the quarter, compared to analyst estimates of $21.13 million. Flora Growth had a negative net margin of 84.86% and a negative trailing twelve-month return on equity of 56.02%.

What ETF holds Flora Growth's stock ?: Global X Cannabis ETF holds 443,087 shares of FLGC stock, representing 3.38% of its portfolio.
When did Flora Growth's stock split?: Shares of Flora Growth reverse split on the morning of Friday, June 9th 2023. The 1-20 reverse split was announced on Friday, June 9th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 9th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
When did Flora Growth IPO?: (FLGC) raised $15 million in an initial public offering (IPO) on Tuesday, May 11th 2021. The company issued 3,300,000 shares at $4.00-$5.00 per share. Boustead Securities served as the underwriter for the IPO.
Who are Flora Growth's major shareholders?: Flora Growth's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (7.24%) and Armistice Capital LLC (5.45%).
How do I buy shares of Flora Growth?: Shares of FLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:FLGC) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial